| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
| filingDate |
2001-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4ed9aa0a950b9bf1e22c61612846481 |
| publicationDate |
2003-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6518246-B1 |
| titleOfInvention |
Pharmaceutical composition and method for the treatment of neoplastic cells |
| abstract |
A pharmaceutical composition and method, for treating human or non-human neoplastic disorders, e.g. colorectal disorders, comprising the administration of pharmaceutically effective amounts of galanin, octreotide and serotonin in a pharmaceutically acceptable carrier. The effective amount is 10 mug/kg body weight to about 60 mug/kg body weight of each of the three, preferably about 10 mug/kg to about 20 mug/kg of each of the three. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003092042-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010204114-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005123575-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009005693-A1 |
| priorityDate |
2001-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |